Journal: BMC Neurology

Article Title: Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study

doi: 10.1186/s12883-022-02986-7

Figure Lengend Snippet: Overview of the assessments conducted at specified visits (optional parts are given in brackets)

Article Snippet: questionnaires completed on site , NAS, GSLTPAQ, PDDS, MSWS-12, ABC-Scale, FSS, FSMC, PROMIS cognitive abilities, BPI, PainDETECT, BDI-II, HAQUAMS, PROMIS general health , x , x , x , (x).

Techniques: Biomarker Discovery, Sequencing, Bacteria, Clinical Proteomics, Magnetic Resonance Imaging

Journal: American Journal of Alzheimer's Disease and Other Dementias

Article Title: Cognitive Screening in Persons With Chronic Diseases in Primary Care

doi: 10.1177/1533317515577127

Figure Lengend Snippet: Self-Administered and Telephone-Administered Cognitive Screening.

Article Snippet: Name of the Measure Administration Time Domains Assessed 103 Patient Reported Outcomes in Cognitive Impairment (PROCOG) 30 minutes Executive function, Navigation, social functioning, leisure time, self-esteem, mood, and functional status 104 Patient-Reported Outcome Measurement information System (PROMIS) Cognitive Concerns and Ability Scale 30-40 minutes Perception of one’s cognitive ability with regard to concentration and memory The self-reported version of the scale 105 Self-Administered Gerocognitive Examination (SAGE) 12-15 minutes Language, executive, memory, reasoning, visuospatial, and orientation 106 Test your memory (TYM) 12-15 minutes Orientation, copying, memory (antegrade and retrograde), calculations, visuospatial, and naming 107 Blessed Telephone Information Memory Concentration Test 6-10 minutes Memory and concentration Telephone screening measures 108 Brief Test of Adult Cognition by Telephone (BTACT) 20 minutes Episodic memory, working memory, reasoning, verbal fluency, processing speed, and executive function 109 Modified TICS (TICS-M) 12-15 minutes 13-Item, wordlist, orientation, memory, and language 110 Structured Telephone Interview for Dementia Assessment (STIDA) 15-40 minutes Memory, orientation, judgment and problem solving.

Techniques: Functional Assay, Concentration Assay, Modification, Battery

Journal: American Journal of Alzheimer's Disease and Other Dementias

Article Title: Cognitive Screening in Persons With Chronic Diseases in Primary Care

doi: 10.1177/1533317515577127

Figure Lengend Snippet: Technology-Based Cognitive Screening Measures.

Article Snippet: Name of the Measure Administration Time Domains Assessed 103 Patient Reported Outcomes in Cognitive Impairment (PROCOG) 30 minutes Executive function, Navigation, social functioning, leisure time, self-esteem, mood, and functional status 104 Patient-Reported Outcome Measurement information System (PROMIS) Cognitive Concerns and Ability Scale 30-40 minutes Perception of one’s cognitive ability with regard to concentration and memory The self-reported version of the scale 105 Self-Administered Gerocognitive Examination (SAGE) 12-15 minutes Language, executive, memory, reasoning, visuospatial, and orientation 106 Test your memory (TYM) 12-15 minutes Orientation, copying, memory (antegrade and retrograde), calculations, visuospatial, and naming 107 Blessed Telephone Information Memory Concentration Test 6-10 minutes Memory and concentration Telephone screening measures 108 Brief Test of Adult Cognition by Telephone (BTACT) 20 minutes Episodic memory, working memory, reasoning, verbal fluency, processing speed, and executive function 109 Modified TICS (TICS-M) 12-15 minutes 13-Item, wordlist, orientation, memory, and language 110 Structured Telephone Interview for Dementia Assessment (STIDA) 15-40 minutes Memory, orientation, judgment and problem solving.

Techniques: Concentration Assay

Journal: Therapeutic Advances in Rare Disease

Article Title: 27th Annual Conference of the United Mitochondrial Disease Foundation Abstracts - Mitochondrial Medicine 2024 - Cleveland, Ohio – June 26-29, 2024

doi: 10.1177/26330040241276322

Figure Lengend Snippet:

Article Snippet: The goals of this qualitative study were to 1) identify the key signs, symptoms, and impacts of MELAS from patient and therapeutic-area clinical expert perspectives; 2) evaluate the Patient-Reported Outcomes Measurement Information System (PROMIS®) Fatigue Mitochondrial Disease Short Form and the draft PROMIS Cognitive Function MELAS Short Form for use in adult MELAS patients; and 3) compare the content assessed by the PROMIS questionnaires and performance outcomes measures (PerfOs; 30 Second Sit-to-Stand and tests of cognitive functioning) to clinician- and patient-reported signs, symptoms, and impacts.

Techniques: Variant Assay, Activation Assay, Selection, Mutagenesis, CRISPR, Generated, Inhibition, Knock-Out, Sequencing, In Vivo, Derivative Assay, Sterility, Activity Assay, Virus, Diagnostic Assay, Next-Generation Sequencing, Biomarker Assay, Animal Model, Comparison